Private equity group Nordic Capital has completed its $846m takeover of Advanz Pharma, in a move that the pair say will “bring significant investment and expertise to help fuel Advanz Pharma’s growth, with the potential to bring further cost-savings to the [UK] National Heath Service and wider European healthcare systems while enhancing choice and access to critical medicines globally.”
The $17.26-per-share deal had been announced in January and billed as the second largest sale of a UK-based specialty pharmaceutical...
